Aptar Pharma, part of Crystal Lake-based AptarGroup Inc., said Monday it has developed its first metal-free, multidose nasal spray pump specifically designed for recyclability.
30.01.2023 - Aptar Pharma, part of AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery systems, services and active material science solutions, today announces the launch of APF Futurity, its first metal-free, multidose nasal spray pump developed to . Seite 1
/PRNewswire/ The "Connected Drug Delivery Devices Market By Type, By Technology, By End-use: Global Opportunity Analysis and Industry Forecast, 2021-2030".
/PRNewswire/ Forecasts by Product Type (Standard Pressurised Metered-Dose Inhalers, Pressurised Metered-dose Inhalers, Metered-Dose Inhaler with a Spacer,.
Aptar Pharma has delivered the first phase of its previously announced expansion program of approximately $180 million to meet growing customer capacity needs.